Executive summary
The Vaccine Development and Evaluation Centre (VDEC) has developed a standardised assay as a tool to screen compound libraries against Mycobacterium tuberculosis in conjunction with a commonly used chemotherapy drug, to both reduce the development of antimicrobial resistance (AMR) and hopefully improve patient treatment.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.